For decades, we've been told “Lower LDL is Better.” But what if, in our myopic obsession with LDL and ApoB, we’ve missed a ...

Please provide your email address to receive an email when new articles are posted on . ApoA-I infusions may improve outcomes after acute heart attack for patients with multivessel CAD and ...

Study deciphers the molecular handshake between LDL receptors and apoB100, shedding light on cholesterol metabolism and its role in cardiovascular disease. Study: Structure of apolipoprotein B100 ...

My cholesterol has been on the rise for the past few years – and not just a slow creep. For most of my life, my LDL (often referred to as ‘bad’ cholesterol) was solidly under 120 mg/dl. Over the past ...

Please provide your email address to receive an email when new articles are posted on . An oral PCSK9 inhibitor lowered LDL cholesterol by up to 60% and improved other lipid parameters at 24 weeks.

Plus, exactly how many calories to burn each week to improve your cholesterol numbers.

Enlicitide, an oral PCSK9 inhibitor, reduced LDL-C by nearly 60% in adults with or at risk for ASCVD. The medication offers a daily oral alternative to injectable PCSK9 inhibitors, potentially ...